Inflammatory bowel disease

  • Inflammato.ry bowel disease (IBD) is a chronic inflammatory disease that is difficult to limit clear causes such as genetic and environmental factors, and Crohn's disease and ulcerative colitis are representative diseases.

  • As of 2019, 8 million patients worldwide suffer from inflammatory bowel disease.

  • In a study through animal experiments, it was confirmed that the symptom, which decreases in length due to intestinal loss due to IBD, was restored to a normal level through IntenCell® administration.

  • Unlike current treatments limited to inhibiting or alleviating symptoms, IntenCell® will be an excellent treatment for IBD by helping regenerate intestinal tissue along with previously known excellent anti-inflammatory effects.